The Vanguard Group Discloses Significant Stake in Spire Healthcare

The Vanguard Group, Inc. has publicly disclosed its opening position regarding Spire Healthcare Group plc. According to Form 8.3, Vanguard holds a 3.59% interest in Spire's securities, equating to 14,469,628 ordinary shares. This disclosure follows the procedures outlined in Rule 8.3 of the Takeover Code, which concerns parties owning 1% or more of relevant securities. The form indicates that there are currently no short positions, cash-settled derivative transactions, or agreements being pursued by Vanguard in relation to Spire Healthcare's securities.

On March 26, 2026, Vanguard reported selling 9,878 ordinary shares of Spire at a price of 1.46 GBP per share. There are no other notable arrangements, agreements, or derivative interests disclosed in this document. Vanguard has confirmed that no supplemental form detailing any open positions has been attached. The disclosure was published on March 27, 2026, and any inquiries can be directed to Shawn Acker at the provided contact number.